ArticleOrphanet journal of rare diseases2026
WFS1-related isolated diabetes induced by a WFS1 missense mutation: focus on the isolated diabetes phenotype.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWolfram syndrome is a rare disease caused by the mutation of WFS1 gene, characterized as s spectrum of disorders. We aim to investigate the clinical features and pathogenic mechanisms of a WFS1 missense mutation inducing atypical phenotype characterized solely by isolated diabetes mellitus (DM).
resultsProband and her extended families were investigated to identify mutations in the WFS1 gene. Islet function analysis was conducted to assess beta-cell function of the proband and other mutation carriers and the proband was follow-up for five years. HOMA-IR and HOMA-β were calculated to reflect insulin sensitivity and beta-cell function. In vitro experiments were conducted to evaluate the effects of WFS1 mutations. Through transfection of wild type (WT) and mutant WFS1 plasmids into MIN6 cells, we investigate the effects of mutations on endoplasmic reticulum (ER) stress and insulin processing. A missense mutation in WFS1 (c.173 C > T, p.A58V) was identified in a patient with non-syndromic diabetes and five of her family members. Islet function analysis suggested heterogeneity of beta-cell function, with notable differences of HOMA-IR and HOMA-β among the proband and family members. In vitro experiments demonstrated that the WFS1 mutations activates ER stress response, leading to an increase in the levels of p-PERK, XBP1s, ATF4 and pIRE1-α. WFS1 mutations also led to impaired insulin biosynthesis, manifested by the accumulation of proinsulin and an increased proinsulin-to-insulin ratio.
conclusionThe p.A58V WFS1 mutation is implicated in a non-syndromic DM phenotype and variable beta-cell function. This mutation activates ER stress pathways and disrupts proinsulin processing, offering insights into the molecular pathogenesis of this unique form of WS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.